Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalised human B-cell line GM607 but do not confer tumourigenicity
Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalised human B-cell line GM607 but do not confer tumourigenicity
Eighty-five percent of follicular lymphomas (FL) possess a characteristic t(14;18) translocation that results in the deregulated expression of the proto-oncogene BCL-2. BCL-2 overexpression alone is insufficient for full cellular transformation and at least one other genetic event is believed to be necessary for FL development. Deregulated c-Myc expression has previously been shown to co-operate with Bcl-2 to transform murine fibroblast cell lines and lead to tumor development in mice. We have developed a human model system to study early transformation in lymphoid cells using immortalised lymphoblastoid cells. We sequentially introduced BCL-2 and c-MYC, two proto-oncogenes known to be involved in the transformation of B-cells into EBV immortalised human B cells. We show that the c-Myc and Bcl-2 overexpression, together with EBV immortalization were insufficient to cause full cellular transformation as measured by cell proliferation rates, soft agar and tumourigenicity assays. These results show that more than three genetic hits (EBV infection, BCL-2 and c-MYC overexpression) were required for the full cellular transformation of human lymphoblastoid cells. However, subtle changes in cellular proliferation and sensitivity to apoptosis were documented, at non-limiting dilutions. These changes may confer a susceptibility to the modified cells such that they are more susceptible to the acquisition of additional genetic changes and evolve towards a fully transformed state. In addition, the model system developed may be suitable for the identification of further known and novel oncogenic events involved in the full transformation of B-cells
Bcl-2, c-Myc, lymphoma, apoptosis, transformation
581-592
Tomlin, Jennifer L.
ccd970de-752b-414e-aba5-1c85adf8bc0d
Guinn, Barbara-Ann
728d28c9-a23d-413a-ba1d-4531005705d7
Penn, Linda Z.
a68d57c5-360b-41f3-9fa0-42a6c5c78801
Berinstein, Neil L.
7bdb1cdc-f5e4-4e45-b08a-220de9789a17
April 2005
Tomlin, Jennifer L.
ccd970de-752b-414e-aba5-1c85adf8bc0d
Guinn, Barbara-Ann
728d28c9-a23d-413a-ba1d-4531005705d7
Penn, Linda Z.
a68d57c5-360b-41f3-9fa0-42a6c5c78801
Berinstein, Neil L.
7bdb1cdc-f5e4-4e45-b08a-220de9789a17
Tomlin, Jennifer L., Guinn, Barbara-Ann, Penn, Linda Z. and Berinstein, Neil L.
(2005)
Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalised human B-cell line GM607 but do not confer tumourigenicity.
Leukemia and Lymphoma, 46 (4), .
(doi:10.1080/10428190400019867).
Abstract
Eighty-five percent of follicular lymphomas (FL) possess a characteristic t(14;18) translocation that results in the deregulated expression of the proto-oncogene BCL-2. BCL-2 overexpression alone is insufficient for full cellular transformation and at least one other genetic event is believed to be necessary for FL development. Deregulated c-Myc expression has previously been shown to co-operate with Bcl-2 to transform murine fibroblast cell lines and lead to tumor development in mice. We have developed a human model system to study early transformation in lymphoid cells using immortalised lymphoblastoid cells. We sequentially introduced BCL-2 and c-MYC, two proto-oncogenes known to be involved in the transformation of B-cells into EBV immortalised human B cells. We show that the c-Myc and Bcl-2 overexpression, together with EBV immortalization were insufficient to cause full cellular transformation as measured by cell proliferation rates, soft agar and tumourigenicity assays. These results show that more than three genetic hits (EBV infection, BCL-2 and c-MYC overexpression) were required for the full cellular transformation of human lymphoblastoid cells. However, subtle changes in cellular proliferation and sensitivity to apoptosis were documented, at non-limiting dilutions. These changes may confer a susceptibility to the modified cells such that they are more susceptible to the acquisition of additional genetic changes and evolve towards a fully transformed state. In addition, the model system developed may be suitable for the identification of further known and novel oncogenic events involved in the full transformation of B-cells
This record has no associated files available for download.
More information
Submitted date: April 2005
Published date: April 2005
Keywords:
Bcl-2, c-Myc, lymphoma, apoptosis, transformation
Identifiers
Local EPrints ID: 71576
URI: http://eprints.soton.ac.uk/id/eprint/71576
ISSN: 1042-8194
PURE UUID: ace9d36e-5c28-4f25-a679-1217b99777d4
Catalogue record
Date deposited: 14 Dec 2009
Last modified: 13 Mar 2024 20:33
Export record
Altmetrics
Contributors
Author:
Jennifer L. Tomlin
Author:
Barbara-Ann Guinn
Author:
Linda Z. Penn
Author:
Neil L. Berinstein
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics